190 related articles for article (PubMed ID: 33061812)
1. Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase.
Long Q; Hua Y; He L; Zhang C; Sui S; Li Y; Qiu H; Tian T; An X; Luo G; Yan Y; Zhao A; Shi D; Xie F; Chen M; Zheng F; Deng W
Int J Biol Sci; 2020; 16(15):3002-3017. PubMed ID: 33061812
[No Abstract] [Full Text] [Related]
2. PUF60 promotes glioblastoma progression through regulation of EGFR stability.
Wang F; Peng L; Sun Y; Zhang B; Lu S
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):190-196. PubMed ID: 36335869
[TBL] [Abstract][Full Text] [Related]
3. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.
Casuscelli J; Becerra MF; Manley BJ; Zabor EC; Reznik E; Redzematovic A; Arcila ME; Tennenbaum DM; Ghanaat M; Kashan M; Stief CG; Carlo M; Voss MH; Feldman DR; Motzer RJ; Chen Y; Reuter VE; Coleman JA; Russo P; Hsieh JJ; Hakimi AA
Eur Urol Focus; 2019 Jul; 5(4):642-649. PubMed ID: 28951115
[TBL] [Abstract][Full Text] [Related]
5. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
[TBL] [Abstract][Full Text] [Related]
6. TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.
Wang K; Liu T; Liu L; Liu J; Liu C; Wang C; Ge N; Ren H; Yan K; Hu S; Björkholm M; Fan Y; Xu D
Oncotarget; 2014 Apr; 5(7):1829-36. PubMed ID: 24742867
[TBL] [Abstract][Full Text] [Related]
7. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D
Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105
[TBL] [Abstract][Full Text] [Related]
8. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
Lee DD; Leão R; Komosa M; Gallo M; Zhang CH; Lipman T; Remke M; Heidari A; Nunes NM; Apolónio JD; Price AJ; De Mello RA; Dias JS; Huntsman D; Hermanns T; Wild PJ; Vanner R; Zadeh G; Karamchandani J; Das S; Taylor MD; Hawkins CE; Wasserman JD; Figueiredo A; Hamilton RJ; Minden MD; Wani K; Diplas B; Yan H; Aldape K; Akbari MR; Danesh A; Pugh TJ; Dirks PB; Castelo-Branco P; Tabori U
J Clin Invest; 2019 Jan; 129(1):223-229. PubMed ID: 30358567
[TBL] [Abstract][Full Text] [Related]
9. Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression.
Sun S; Nakashima K; Ito M; Li Y; Chida T; Takahashi H; Watashi K; Sawasaki T; Wakita T; Suzuki T
Sci Rep; 2017 Oct; 7(1):12874. PubMed ID: 28993636
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α-Mediated Telomerase Reverse Transcriptase Activation Inducing Autophagy Through Mammalian Target of Rapamycin Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress.
Song H; Chen X; Jiao Q; Qiu Z; Shen C; Zhang G; Sun Z; Zhang H; Luo QY
Thyroid; 2021 Feb; 31(2):233-246. PubMed ID: 32772829
[No Abstract] [Full Text] [Related]
11. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
[TBL] [Abstract][Full Text] [Related]
12. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C.
Xu N; Ren Y; Bao Y; Shen X; Kang J; Wang N; Wang Z; Han X; Li Z; Zuo J; Wei GH; Wang Z; Zong WX; Liu W; Xie G; Wang Y
Cell Rep; 2023 Sep; 42(9):113041. PubMed ID: 37682709
[TBL] [Abstract][Full Text] [Related]
13. CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Kumar M; Witt B; Knippschild U; Koch S; Meena JK; Heinlein C; Weise JM; Krepulat F; Kuchenbauer F; Iben S; Rudolph KL; Deppert W; Günes C
Int J Cancer; 2013 May; 132(9):2032-43. PubMed ID: 23023397
[TBL] [Abstract][Full Text] [Related]
14. TERT promoter mutations and telomeres during tumorigenesis.
Lorbeer FK; Hockemeyer D
Curr Opin Genet Dev; 2020 Feb; 60():56-62. PubMed ID: 32163830
[TBL] [Abstract][Full Text] [Related]
15. Telomerase reverse transcriptase (TERT) promoter mutation correlated with intratumoral heterogeneity in hepatocellular carcinoma.
Kwa WT; Effendi K; Yamazaki K; Kubota N; Hatano M; Ueno A; Masugi Y; Sakamoto M
Pathol Int; 2020 Sep; 70(9):624-632. PubMed ID: 32559017
[TBL] [Abstract][Full Text] [Related]
16.
Long Q; An X; Chen M; Wang N; Sui S; Li Y; Zhang C; Lee K; Wang X; Tian T; Pan Y; Qiu H; Xie F; Deng W; Zheng F; He L
Front Oncol; 2020; 10():568015. PubMed ID: 33117697
[TBL] [Abstract][Full Text] [Related]
17. Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects.
Landa I; Thornton CEM; Xu B; Haase J; Krishnamoorthy GP; Hao J; Knauf JA; Herbert ZT; Martínez P; Blasco MA; Ghossein R; Fagin JA
Mol Cancer Res; 2023 Nov; 21(11):1163-1175. PubMed ID: 37478162
[TBL] [Abstract][Full Text] [Related]
18. EGR2-mediated regulation of m
Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
[TBL] [Abstract][Full Text] [Related]
19. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
20. lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR‑200c‑5p/collagen type XI α1 chain pathway.
Xu C; Liang H; Zhou J; Wang Y; Liu S; Wang X; Su L; Kang X
Mol Med Rep; 2020 Nov; 22(5):3677-3686. PubMed ID: 32901847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
